Administration of Bacillus Calmette-Guerin (BCG) has been shown to cause granulomatous prostatitis, a rare inflammatory process that can be mistaken for prostate cancer.
We present a case of a 78-year-old man on active surveillance for prostate cancer with a subsequent diagnosis of high-grade urothelial carcinoma. After intravesical BCG therapy, he developed chronic granulomatous prostatitis. We present serial magnetic resonance imaging and biopsy data demonstrating the time interval between BCG administration and the manifestation of chronic granulomatous prostatitis.
Written by:
Logan JK, Walton-Diaz A, Rais-Bahrami S, Merino MJ, Turkbey B, Choyke PL, Pinto PA. Are you the author?
Urologic Oncology Branch, Laboratory of Pathology, Molecular Imaging Program, and Center for Interventional Oncology, National Cancer Institute, National Institutes of Health, Bethesda, MD.
Reference: J Comput Assist Tomogr. 2014 Jan 20. Epub ahead of print.
doi: 10.1097/RCT.0000000000000014
PubMed Abstract
PMID: 24448508
UroToday.com Prostatitis Section
